New avenues for anti-inflammatory therapy

Research output: Contribution to journalShort SurveyOtherpeer-review

Abstract

A new study identifies the chemokine CCL27 and its receptor CCR10 as important homing molecules for T-cell migration to the skin. Moreover, they find that CCL27 inhibition suppresses some skin-inflammatory responses, suggesting that therapies targeting CCL10 could be used to treat several human skin disorders.

Original languageEnglish
Pages (from-to)117-118
Number of pages2
JournalNature Medicine
Volume8
Issue number2
DOIs
Publication statusPublished - 27 Feb 2002
Externally publishedYes

Cite this

@article{9c33880360db4b49ae597bd36ee7d443,
title = "New avenues for anti-inflammatory therapy",
abstract = "A new study identifies the chemokine CCL27 and its receptor CCR10 as important homing molecules for T-cell migration to the skin. Moreover, they find that CCL27 inhibition suppresses some skin-inflammatory responses, suggesting that therapies targeting CCL10 could be used to treat several human skin disorders.",
author = "Mackay, {Charles R.}",
year = "2002",
month = "2",
day = "27",
doi = "10.1038/nm0202-117",
language = "English",
volume = "8",
pages = "117--118",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "2",

}

New avenues for anti-inflammatory therapy. / Mackay, Charles R.

In: Nature Medicine, Vol. 8, No. 2, 27.02.2002, p. 117-118.

Research output: Contribution to journalShort SurveyOtherpeer-review

TY - JOUR

T1 - New avenues for anti-inflammatory therapy

AU - Mackay, Charles R.

PY - 2002/2/27

Y1 - 2002/2/27

N2 - A new study identifies the chemokine CCL27 and its receptor CCR10 as important homing molecules for T-cell migration to the skin. Moreover, they find that CCL27 inhibition suppresses some skin-inflammatory responses, suggesting that therapies targeting CCL10 could be used to treat several human skin disorders.

AB - A new study identifies the chemokine CCL27 and its receptor CCR10 as important homing molecules for T-cell migration to the skin. Moreover, they find that CCL27 inhibition suppresses some skin-inflammatory responses, suggesting that therapies targeting CCL10 could be used to treat several human skin disorders.

UR - http://www.scopus.com/inward/record.url?scp=0036173457&partnerID=8YFLogxK

U2 - 10.1038/nm0202-117

DO - 10.1038/nm0202-117

M3 - Short Survey

VL - 8

SP - 117

EP - 118

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 2

ER -